EFFECT OF TOLFENAMIC ACID IN RHEUMATOID ARTHRITISKAJANDER A; LAINE V; GOTHONI G et al.1972; SCAND. J. RHEUMATOL.; SWED.; DA. 1972; VOL. 1; NO 2; PP. 91-93; BIBL. 8REF.Serial Issue

OSTEOARTHRITIS OF THE KNEE TREATED WITH TOLFENAMIC ACID = OSTEOARTHRITE DU GENOU TRAITEE PAR L'ACIDE TOLFENAMIQUEZACHARIAE E; SYLVEST J.1972; SCAND. J. RHEUMATOL.; SWED.; DA. 1972; VOL. 1; NO 3; PP. 97-99; BIBL. 9REF.Serial Issue

PROPHYLACTIC TREATMENT OF MIGRAINE WITH TOLFENAMIC ACIDMIKKELSEN BM; FALK JV.1982; ACTA NEUROL. SCAND.; ISSN 0001-6314; DNK; DA. 1982; VOL. 66; NO 1; PP. 105-111; BIBL. 12 REF.Article

EFFECT OF TOPICAL VEHICLE COMPOSITION ON THE RELEASE OF TOLFENAMIC ACID IN VITRORAUNIO O; JUSLIN M; JUUTILAINEN P et al.1980; ACTA PHARM. FENN.; ISSN 0356-3456; FIN; DA. 1980; VOL. 89; NO 4; PP. 267-273; BIBL. 23 REF.Article

TOLFENAMIC ACID IN ANKYLOSING SPONDYARTHRITIS: A DOUBLE-BLIND COMPARISON TO INDOMETHACINREJHOLEC V; VAPAATALO H; TOKOLA O et al.1980; SCAND. J. RHEUMATOL., SUPPL.; ISSN 0301-3847; SWE; DA. 1980; NO 36; 7 P.; BIBL. 24 REF.Serial Issue

TOLFENAMIC ACIDS IS AS EFFECTIVE AS ERGOTAMINE DURING MIGRAINE ATTACKSHAKKARAINEN H; VAPAATALO H; GOTHONI G et al.1979; LANCET; GBR; DA. 1979; NO 8138; PP. 326-327; BIBL. 11 REF.Article

A DOUBLE-BLIND CLINICAL STUDY ON LONG-TERM USE OF OXYPHENBUTAZONE AND TOLFENAMIC ACID IN CONNECTION WITH TELECOBALT THERAPY = UNE ETUDE CLINIQUE A DOUBLE INSU SUR L'EMPLOI A LONG TERME DE L'OXYPHENBUTAZONE ET DE L'ACIDE TOLFENAMIQUE EN ASSOCIATION AVEC LA TELECOBALTOTHERAPIEKAUPPILA A; VAPAATALO H; TASKINEN PJ et al.1975; ARZNEIMITTEL FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 7; PP. 1082-1085; ABS. ALLEM.; BIBL. 8REF.Article

HUMAN PHARMACOKINETICS OF TOLFENAMIC ACID, A NEW ANTI-INFLAMMATORY AGENTPENTIKAINEN PJ; NEUVONEN PJ; BACKMAN C et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 19; NO 5; PP. 359-365; BIBL. 22 REF.Article

A COMPARISON OF THE ANALGETIC EFFICACY OF RIMAZOLMETHYLSULPHATE AND TOLFENAMIC ACID IN PATIENTS WITH POSTOPERATIVE OR POSTTRAUMATIC PAINHAATAJA M; LINNA T; HIETULA M et al.1978; CURR. THERAPEUT. RES.; USA; DA. 1978; VOL. 24; NO 3; PP. 284-287; BIBL. 9 REF.Article

ANTI-PROSTAGLANDIN THERAPY IN PREVENTION OF SIDE EFFECTS OF INTRAUTERINE CONTRACEPTIVE DEVIEESYLIKORKALA O; KAUPPILA A; SILJANDER M et al.1978; LANCET; GBR; DA. 1978; NO 8086; PP. 393-395; BIBL. 28 REF.Article

Effect of diclofenac sodium, tolfenamic acid and indomethacin on the production of superoxide induced by N-formyl-methionyl-leucyl-phenylalanine in normal human polymorphonuclear leukocytesFRIMAN, C; JOHNSTON, C; CHEW, C et al.Scandinavian journal of rheumatology. 1986, Vol 15, Num 1, pp 41-46, issn 0300-9742Article

Release of tolfenamic acid from suppository basesRAUNIO, O; TURAKKA, L; MAKELA, K et al.S.T.P. pharma. 1985, Vol 1, Num 4, pp 275-280Article

Etude clinique de l'association pentoil-antiinflammatoires acides dans la lombalgieSUZUKI, T.Yakuri to chiryo. 1987, Vol 15, Num 1, pp 447-452, issn 0386-3603Article

Expérience clinique du Clotam dans la polyarthrite rhumatoïde et l'ostéoarthrose du genouTAKEUCHI, S.Yakuri to chiryo. 1986, Vol 14, Num 7, pp 485-497, issn 0386-3603Article

Effects of migraine attack and metoclopramide on the absorption of tolfenamic acidTOKOLA, R. A; NEUVONEN, P. J.British journal of clinical pharmacology. 1984, Vol 17, Num 1, pp 67-75, issn 0306-5251Article

Essai clinique du CLOTAM dans l'ostéoarthrite du genouOGATA, K; SUGIOKA, Y.Yakuri to chiryo. 1986, Vol 14, Num 1, pp 393-402, issn 0386-3603Article

Expérience clinique du CLOTAM dans la polyarthrite rhumatoïdeUEO, T; OKUMURA, H.Yakuri to chiryo. 1986, Vol 14, Num 4, pp 967-971, issn 0386-3603Article

Expérience clinique du Clotam® dans l'ostéoarthriteSAIKA, M.Yakuri to chiryo. 1986, Vol 14, Num 11, pp 471-481, issn 0386-3603Article

Etude clinique du CLOTAM dans la lombalgieYOSHIZAWA, N.Yakuri to chiryo. 1986, Vol 14, Num 7, pp 499-504, issn 0386-3603Article

Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liverSTENDERUP, J; ERIKSEN, J; BOLS PEDERSEN, S et al.European journal of clinical pharmacology. 1985, Vol 28, Num 5, pp 573-579, issn 0031-6970Article

TOLFENAMIC ACID: DETECTION AND STRUCTURE OF URINARY METABOLITESPEDERSEN SB; ALHEDE B; BUCHARDT O et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 11; PP. 1944-1948; ABS. GER; BIBL. 14 REF.Article

ORAL ANTIPYRETIC THERAPY: EVALUATION OF SULINDAC AS AN ANTIPYRETIC AGENTSIMILA S; KEINANEN KIUKAANIEMI S; KOUVALAINEN K et al.1979; CURR. THERAPEUT. RES.; USA; DA. 1979; VOL. 26; NO 6; SECT. 1; PP. 828-833; BIBL. 7 REF.Article

INHIBITION OF PROSTAGLANDIN BIOSYNTHESIS BY TOLFENAMIC ACID IN VITRO.LINDEN IB; PARANTAINEN J; VAPAATALO H et al.1976; SCAND. J. RHEUMATOL.; SWED.; DA. 1976; VOL. 5; NO 3; PP. 129-132; BIBL. 18 REF.Article

PROSTAGLANDIN BIOSYNTHESIS INHIBITORS AND ENDOMETRIOSISKAUPPILA A; PUOLAKKA J; YLIKORKALA O et al.1979; PROSTAGLANDINS; USA; DA. 1979; VOL. 18; NO 4; PP. 655-661; BIBL. 18 REF.Article

ANTIPYRETIC ANALGESICS IN PATIENTS ON ANTIEPILEPTIC DRUG THERAPYNEUVONEN PJ; LEHTOVAARA R; BARDY A et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 15; NO 4; PP. 263-268; BIBL. 23 REF.Article